Literature DB >> 2170017

The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites.

J H Adams1, D E Hudson, M Torii, G E Ward, T E Wellems, M Aikawa, L H Miller.   

Abstract

Plasmodium vivax and Plasmodium knowlesi merozoites invade human erythrocytes that express Duffy blood group surface determinants. A soluble parasite protein of 135 kd binds specifically to a human Duffy antigen. Using antisera affinity purified on the 135 kd protein, we cloned a gene that encodes a member of a P. knowlesi family of erythrocyte binding proteins. The gene is a member of a family that includes three homologous genes located on separate chromosomes. Two genes are expressed as major membrane-bound products that give rise to soluble erythrocyte binding proteins: the 135 kd Duffy binding protein and a 138 kd protein that binds only rhesus erythrocytes. These different erythrocyte binding specificities may result from sequence divergence of the homologous genes. The Duffy receptor family is localized in micronemes, an organelle found in all organisms of the phylum Apicomplexa.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170017     DOI: 10.1016/0092-8674(90)90295-p

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  99 in total

1.  Expression of polymorphic msp1beta genes during acute anaplasma Marginale rickettsemia.

Authors:  M Camacho-Nuez; M de Lourdes Muñoz; C E Suarez; T C McGuire; W C Brown; G H Palmer
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Two conserved amino acid motifs mediate protein targeting to the micronemes of the apicomplexan parasite Toxoplasma gondii.

Authors:  M Di Cristina; R Spaccapelo; D Soldati; F Bistoni; A Crisanti
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

3.  Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.

Authors:  Sedigheh Zakeri; Laleh Babaeekhou; Akram Abouie Mehrizi; Maryam Abbasi; Navid Dinparast Djadid
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

4.  Analysis of polymorphic regions of Plasmodium vivax Duffy binding protein of Korean isolates.

Authors:  W G Kho; J Y Chung; E J Sim; D W Kim; W C Chung
Journal:  Korean J Parasitol       Date:  2001-06       Impact factor: 1.341

Review 5.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

6.  Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells.

Authors:  G H Mitchell; A W Thomas; G Margos; A R Dluzewski; L H Bannister
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies.

Authors:  Patchanee Chootong; Francis B Ntumngia; Kelley M VanBuskirk; Jia Xainli; Jennifer L Cole-Tobian; Christopher O Campbell; Tresa S Fraser; Christopher L King; John H Adams
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

8.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

9.  Natural variation within the principal adhesion domain of the Plasmodium vivax duffy binding protein.

Authors:  T Tsuboi; S H Kappe; F al-Yaman; M D Prickett; M Alpers; J H Adams
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein.

Authors:  Edwin Chen; Nichole D Salinas; Yining Huang; Francis Ntumngia; Manolo D Plasencia; Michael L Gross; John H Adams; Niraj Harish Tolia
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.